| 2-AG | anandamide and 2-arachidonoylglycerol |
| ACE | angiotensin-converting enzyme |
| AEA | Arachidonoylethanolamide |
| ALP | alkaline phosphatase |
| ALT | alanine aminotransferase |
| ANF | atrial natriuretic factor |
| ARBs | angiotensin receptor blockers |
| AST | aspartate aminotransferase |
| ATP | adenosine triphosphate |
| BMI | Body mass index |
| BNP | B-type natriuretic peptide |
| CB-1 | cannabinoid receptor type 1 |
| CBRs | cannabinoid receptors |
| CCM | cirrhotic cardiomyopathy |
| CCTA | coronary computed tomography angiography |
| CFR | coronary flow reserve |
| CRP | C-reactive protein |
| cTnC | troponin C |
| cTnI | troponin I |
| FetA | Fetuin-A |
| FGF21 | fibroblast growth factor 21 |
| GGT | gamma-glutamyltransferase |
| Il-1 β | interleukin 1 beta |
| iNOs | nitric oxide synthetase |
| INR | International Normalized Ratio |
| ITVR | isovolumetric relaxation time |
| LDH | lactate dehydrogenase |
| LDL-C | low-density lipoprotein cholesterol |
| LT | liver transplantation |
| LVAD | left ventricular assistive device support |
| MED13 | mediator complex subunit 13 |
| miR-208a | microRNA-208a |
| mtDNA | mitochondrial DNA |
| Myh6 | myosin Heavy Chain 6 |
| NAFL | nonalcoholic fatty liver |
| NAFLD | nonalcoholic fatty liver disease |
| NASH | nonalcoholic steatohepatitis |
| NFS | NAFLD Fibrosis Score |
| NF-κB | nuclear factor κB |
| NLRP3 | NOD-like receptor protein 3 |
| NO | nitric oxide |
| PAI-1 | plasminogen inhibitor activator 1 |
| PKA | protein kinase A |
| ROS | reactive oxygen species |
| TGF-β1 | transforming growth factor-β1 |
| TTC | Takotsubo cardiomyopathy |
| VLDL-C | low-density lipoprotein cholesterol |